Are side-chain oxidized oxysterols regulators also in vivo?

Oxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain ox...

Full description

Bibliographic Details
Main Author: Ingemar Bjo¨rkhem
Format: Article
Language:English
Published: Elsevier 2009-01-01
Series:Journal of Lipid Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520306143
id doaj-4dffd69127994acdbc7c047618e69805
record_format Article
spelling doaj-4dffd69127994acdbc7c047618e698052021-04-28T05:55:51ZengElsevierJournal of Lipid Research0022-22752009-01-0150S213S218Are side-chain oxidized oxysterols regulators also in vivo?Ingemar Bjo¨rkhem0To whom correspondence should be addressed; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, SwedenOxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain oxidized oxysterols may be mediators of many cholesterol-induced regulatory effects. When added to cultured cells in vitro, side-chain oxidized oxysterols limit intracellular cholesterol levels by at least three different mechanisms: 1) binding to Insig with subsequent block of the sterol regulatory element-binding proteins (SREBP)-mediated mechanism for regulation of sterol sensitive genes; 2) increasing degradation of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, eventually by a mechanism involving binding of Insig to the enzyme; 3) activation of LXR-mediated stimulation of cholesterol transporters and cholesterol metabolism. Addition of pure unesterified oxysterols to cell cultures is however highly unphysiological, and the in vivo relevance of such experiments is questionable. Transgenic mouse models with markedly reduced or increased concentration of some specific oxysterols do not present marked disturbances in cholesterol turnover and homeostasis. Oxysterol-binding proteins such as LXR have been conclusively shown to be of importance for cholesterol turnover in vivo, but their physiological ligands have not yet been defined with certainty. During the last few years, new experimental data has accumulated supporting the contention that side-chain oxysterols are involved in some LXR-mediated regulation in vivo, at least in some biological systems. The new findings will be critically reviewed here.http://www.sciencedirect.com/science/article/pii/S002222752030614327-Hydroxycholesterol24S-hydroxycholesterol25-hydroxycholesterol24,25-epoxycholesterol
collection DOAJ
language English
format Article
sources DOAJ
author Ingemar Bjo¨rkhem
spellingShingle Ingemar Bjo¨rkhem
Are side-chain oxidized oxysterols regulators also in vivo?
Journal of Lipid Research
27-Hydroxycholesterol
24S-hydroxycholesterol
25-hydroxycholesterol
24,25-epoxycholesterol
author_facet Ingemar Bjo¨rkhem
author_sort Ingemar Bjo¨rkhem
title Are side-chain oxidized oxysterols regulators also in vivo?
title_short Are side-chain oxidized oxysterols regulators also in vivo?
title_full Are side-chain oxidized oxysterols regulators also in vivo?
title_fullStr Are side-chain oxidized oxysterols regulators also in vivo?
title_full_unstemmed Are side-chain oxidized oxysterols regulators also in vivo?
title_sort are side-chain oxidized oxysterols regulators also in vivo?
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 2009-01-01
description Oxsterols are oxygenated metabolites of cholesterol that are short-lived intermediates or end products in cholesterol excretion pathways. They are present in very low concentrations in mammalian systems, always accompanied by a high excess of cholesterol. According to current concepts, side-chain oxidized oxysterols may be mediators of many cholesterol-induced regulatory effects. When added to cultured cells in vitro, side-chain oxidized oxysterols limit intracellular cholesterol levels by at least three different mechanisms: 1) binding to Insig with subsequent block of the sterol regulatory element-binding proteins (SREBP)-mediated mechanism for regulation of sterol sensitive genes; 2) increasing degradation of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase, eventually by a mechanism involving binding of Insig to the enzyme; 3) activation of LXR-mediated stimulation of cholesterol transporters and cholesterol metabolism. Addition of pure unesterified oxysterols to cell cultures is however highly unphysiological, and the in vivo relevance of such experiments is questionable. Transgenic mouse models with markedly reduced or increased concentration of some specific oxysterols do not present marked disturbances in cholesterol turnover and homeostasis. Oxysterol-binding proteins such as LXR have been conclusively shown to be of importance for cholesterol turnover in vivo, but their physiological ligands have not yet been defined with certainty. During the last few years, new experimental data has accumulated supporting the contention that side-chain oxysterols are involved in some LXR-mediated regulation in vivo, at least in some biological systems. The new findings will be critically reviewed here.
topic 27-Hydroxycholesterol
24S-hydroxycholesterol
25-hydroxycholesterol
24,25-epoxycholesterol
url http://www.sciencedirect.com/science/article/pii/S0022227520306143
work_keys_str_mv AT ingemarbjorkhem aresidechainoxidizedoxysterolsregulatorsalsoinvivo
_version_ 1721504949420949504